DSpace@İnönü

Yazar "Idilman, R" için Araştırma Çıktıları | Wos listeleme

Yazar "Idilman, R" için Araştırma Çıktıları | Wos listeleme

Sırala: Sıra: Sonuçlar:

  • Low recurrence rate of hepatocellular carcinoma following ledipasvir and 
    Idilman, R; Demir, M; Aladag, M; Erol, C; Cavus, B; Iliaz, R; Koklu, H; Cakaloglu, Y; Sahin, M; Ersoz, G; Koksal, I; Karasu, Z; Ozgenel, M; Turan, I; Gunduz, F; Ataseven, H; Akdogan, M; Kiyici, M; Koksal, AS; Akhan, S; Gunsar, F; Tabak, F; Kaymakoglu, S; Akarca, US; Akarsu, M; Alkim, H; Araz, F; Ates, F; Aygen, B; Balik, I; Barut, HS; Baysal, B; Bolat, A; Celik, I; Cosgun, S; Ensaroglu, F; Gokcan, H; Gurel, S; Gursoy, S; Inkaya, AC; Kamilli, C; Kav, T; Kuruuzum, Z; Onder, FO; Ormeci, N; Ozbakir, O; Ozenirler, S; Ozer, B; Ozkan, H; Poturoglu, S; Senates, E; Simsek, H; Toka, B; Unal, H; Yaras, S; Yildirim, AE; Yildirim, B; Yilmaz, B; Yilmaz, H; Yozgat, A; Yurdaydin, C (2019)
    The aims of the present study were to evaluate the efficacy and tolerability of ledipasvir/sofosbuvir (LDV/SOF) with or without ribavirin in the treatment of chronic hepatitis C (CHC) in patients with advanced liver disease ...
  • Outcomes following deceased and live donor liver transplantation for the 
    Turan, I; Aladag, M; Harputluoglu, M; Yilmaz, S; Gencdal, G; Polat, KY; Ozcay, F; Akarsu, M; Unek, T; Karasu, Z; Zeytunlu, M; Sumer, HG; Bostanci, EB; Kartal, AC; Balci, D; Dayangac, M; Dincer, D; Adanir, H; Dursun, H; Gulsen, MT; Gunduz, F; Balaban, HY; Kabacam, G; Akyildiz, M; Gunsar, F; Akarca, U; Gurakar, A; Idilman, R (2020)
  • Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and 
    Degertekin, B; Demir, M; Akarca, US; Kani, HT; Ucbilek, E; Yildirim, E; Guzelbulut, F; Balkan, A; Vatansever, S; Danis, N; Demircan, M; Soylu, A; Yaras, S; Kartal, A; Kefeli, A; Gunduz, F; Yalcin, K; Erarslan, E; Aladag, M; Harputluoglu, M; Ozakyol, A; Temel, T; Akarsu, M; Sumer, H; Akin, M; Albayrak, B; Sen, I; Alkim, H; Uyanikoglu, A; Irak, K; Oztaskin, S; Ugurlu, CB; Gunes, S; Gurel, S; Nuriyev, K; Inci, I; Kacar, S; Dincer, D; Doganay, L; Gokturk, HS; Mert, A; Cosar, AM; Dursun, H; Atalay, R; Akbulut, S; Balkan, Y; Koklu, H; Simsek, H; Ozdogan, O; Coban, M; Poturoglu, S; Ayyildiz, T; Yapali, S; Gunsar, F; Akdogan, M; Ozenirler, S; Akyildiz, M; Sezgin, O; Kaymakoglu, S; Besisik, F; Karasu, Z; Idilman, R (2020)
    Background/Aims: This study aimed to evaluate the real-life efficacy and tolerability of direct-acting antiviral treatments for patients with chronic hepatitis C (CHC) with/without cirrhosis in the Turkish population.
  • REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN 
    Yapali, S; Gokcan, H; Harputluoglu, M; Ellik, ZM; Akarsu, M; Durak, S; Gokcen, P; Adanir, H; Ari, D; Mehdiyev, S; Vatansever, S; Guzelbulut, F; Teker, T; Alkim, H; Bilgic, Y; Arslan, M; Ozdil, K; Koc, ES; Etik, DO; Yildirim, E; Balaban, YH; Gunduz, F; Kiyici, M; Akdogan, M; Boyacioglu, S; Ekmen, N; Tozun, N; Simsek, H; Dincer, D; Idilman, R (2021)
  • Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An 
    Efe, C; Dhanasekaran, R; Lammert, C; Ebik, B; Higuera-de la Tijera, F; Aloman, C; Caliskan, AR; Peralta, M; Gerussi, A; Massoumi, H; Catana, AM; Torgutalp, M; Purnak, T; Rigamonti, C; Aldana, AJG; Khakoo, N; Kacmaz, H; Nazal, L; Frager, S; Demir, N; Irak, K; Ellik, ZM; Balaban, Y; Atay, K; Eren, F; Cristoferi, L; Batibay, E; Urzua, A; Snijders, R; Kiyici, M; Akyildiz, M; Ekin, N; Carr, RM; Harputluoglu, M; Hatemi, I; Mendizabal, M; Silva, M; Idilman, R; Silveira, M; Drenth, JPH; Assis, DN; Bjornsson, E; Boyer, JL; Invernizzi, P; Levy, C; Schiano, TD; Ridruejo, E; Wahlin, S (2021)
    Background and Aims Data regarding outcome of COVID-19 in patients with autoimmune hepatitis (AIH) are lacking.
  • Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis 
    Akarsu, M; Onem, S; Turan, I; Adali, G; Akdogan, M; Akyildiz, M; Aladag, M; Balaban, Y; Danis, N; Dayangac, M; Gencdal, G; Gokcan, H; Sertesen, E; Gurakar, M; Harputluoglu, M; Kabacam, G; Karademir, S; Kiyici, M; Idilman, R; Karasu, Z (2021)
    The combination of hepatitis B immunoglobulin and potent nucleos(t)ide analogs after liver transplantation is considered as the standard of care for prophylaxis against hepatitis B virus recurrence. However, the recommended ...
  • Covid-19 in Liver Transplant Recipients: A National Cohort 
    Kabacam, G; Turan, I; Kiyici, M; Ellik, ZM; Dolu, S; Dayangac, M; Ari, D; Gokce, DT; Yildirim, AE; Gencdal, G; Harputluoglu, M; Kartal, A; Demiray, EKD; Gunduz, F; Ergenc, I; Efe, C; Sumer, HG; Kayhan, MA; Gulsen, MT; Akyildiz, M; Arikan, C; Karademir, S; Balci, D; Dundar, Z; Akarsu, M; Gunsar, F; Karasu, Z; Idilman, R (2021)
  • Etiology of Cirrhosis in Turkey: A National Cohort Study 
    Yildirim, AE; Ucbilek, E; Oruncu, MB; Turan, I; Demir, M; Koksal, A; Uyanikoglu, A; Yilmaz, N; Akarsu, M; Tozlu, M; Avcioglu, U; Haktaniyan, B; Aladag, M; Yolacan, R; Toka, B; Kefeli, A; Ormeci, AC; Haciyev, F; Balci, HR; Yurci, MA; Balaban, HY; Fidan, S; Gunduz, F; Gencdal, G; Simsek, C; Ebik, B; Cavus, B; Karatay, E; Sezgin, GC; Yaras, S; Karabulut, U; Gokturk, HS; Uzel, A; Ekin, N; Barutcu, S; Cosar, AM; Keklikkiran, C; Batu, KD; Alkim, H; Acar, S; Yogun, Y; Harputluoglu, M; Yalcin, K; Gunsar, F; Sezgin, O; Akarca, U; Kaymakoglu, S; Karasu, AZ; Ozdogan, OC; Idilman, R (2021)
  • Outcomes following deceased and live donor liver transplantation for the 
    Turan, I; Akarsu, M; Aladass, M; Harputluosslu, M; Yilmaz, S; Gencdal, G; Akyildiz, C; Polat, KY; Ozcay, F; Unek, T; Karasu, Z; Zeytunlu, M; Sumer, HG; Bostanci, EB; Kartal, AC; Balci, D; Dayangac, M; Dincer, D; Adanir, H; Dursun, H; Gulssen, MT; Gunduz, F; Balaban, Y; Kabacam, G; Akyildiz, M; Gunssar, F; Akarca, US; Gurakar, A; Idilman, R (2021)
  • EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B 
    Adanir, H; Etik, DO; Yildirim, AE; Mehdiyev, S; Yapali, S; Cosar, AM; Ari, D; Gokcan, H; Teker, T; Kiyici, M; Balaban, YH; Alkim, H; Ucbilek, E; Unsal, Y; Harputluoglu, M; Vatansever, S; Demir, M; Guzelbulut, F; Gunduz, F; Boyacioglu, S; Bilgic, Y; Ekmen, N; Arslan, M; Simsek, H; Akdogan, M; Dincer, D; Tozun, N; Idilman, R (2021)
  • Effects of immunosuppressive drugs on COVID-19 severity in patients with 
    Efe, C; Lammert, C; Tascilar, K; Dhanasekaran, R; Ebik, B; Higuera-de la Tijera, F; Caliskan, AR; Peralta, M; Gerussi, A; Massoumi, H; Catana, AM; Purnak, T; Rigamonti, C; Aldana, AJG; Khakoo, N; Nazal, L; Frager, S; Demir, N; Irak, K; Melekoglu-Ellik, Z; Kacmaz, H; Balaban, Y; Atay, K; Eren, F; Alvares-da-Silva, MR; Cristoferi, L; Urzua, A; Eskazan, T; Magro, B; Snijders, R; Barutcu, S; Lytvyak, E; Zazueta, GM; Demirezer-Bolat, A; Aydin, M; Heurgue-Berlot, A; De Martin, E; Ekin, N; Yildirim, S; Yavuz, A; Biyik, M; Narro, GC; Kiyici, M; Akyildiz, M; Kahramanoglu-Aksoy, E; Vincent, M; Carr, RM; Gunsar, F; Reyes, EC; Harputluoglu, M; Aloman, C; Gatselis, NK; Ustundag, Y; Brahm, J; Vargas, NCE; Guzelbulut, F; Garcia, SR; Aguirre, J; Anders, M; Ratusnu, N; Hatemi, I; Mendizabal, M; Floreani, A; Fagiuoli, S; Silva, M; Idilman, R; Satapathy, SK; Silveira, M; Drenth, JPH; Dalekos, GN; Assis, DN; Bjornsson, E; Boyer, JL; Yoshida, EM; Invernizzi, P; Levy, C; Montano-Loza, AJ; Schiano, TD; Ridruejo, E; Wahlin, S (2022)
    Background We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods Data of AIH patients with ...
  • Real life efficacy and tolerability of Tenofovir alafenamde fumarate in 
    Gokcan, H; Yapali, S; Harputluoglu, M; Ellik, ZML; Gokcen, P; Adanir, H; Cosar, AM; Durak, S; Ari, D; Mehdiyev, S; Koc, ES; Guzelbulut, F; Alkim, H; Ekmen, N; Yildirim, AE; Unsal, Y; Teker, T; Etik, DO; Vatansever, S; Balaban, HY; Ozdil, K; Arslan, M; Kayhan, MA; Gunduz, F; Kiyici, M; Boyacioglu, S; Simsek, H; Tozun, N; Dincer, D; Idilman, R (2022)
  • Trends and causes of etiology in adult liver transplant patients: 
    Akarsu, M; Harputluoglu, M; Yilmaz, S; Gencdal, G; Akyildiz, M; Polat, KY; Dincer, D; Adanir, H; Turan, I; Gunsar, F; Karasu, Z; Gokcan, H; Karademir, S; Kabacam, G; Kayhan, MA; Kiyici, M; Gulsen, MT; Balaban, HY; Dogrul, AB; Dolu, S; Senkaya, A; Ellik, ZM; Eren, F; Idilman, R (2022)
  • The effect of clinicopathologic findings of hepatocellular carcinoma on 
    Akyildiz, M; Gencdal, G; Ince, V; Harputluoglu, MM; Bozkurt, B; Zeytunlu, M; Kilic, M; Farejov, R; Turan, I; Gunsar, F; Karasu, Z; Yilmaz, UT; Akarsu, M; Kabacam, G; Kirimker, EO; Atay, A; Kayhan, MA; Gokcan, H; Adali, G; Tokat, Y; Emiroglu, R; Polat, KY; Yilmaz, S; Karademir, S; Idilman, R (2022)
  • Real life efficacy and tolerability of tenofovir alafenamde fumarate in 
    Yapali, S; Gokcan, H; Harputluoglu, M; Ellik, ZM; Gokcen, P; Adanir, H; Cosar, AM; Durak, S; Ari, D; Mehdiyev, S; Koc, ES; Guzelbulut, F; Alkim, H; Ekmen, N; Yildirim, AE; Unsal, Y; Teker, T; Etik, DO; Vatansever, S; Balaban, Y; Ozdil, K; Arslan, M; Kayhan, MA; Gunduz, F; Kiyici, M; Boyacioglu, S; Simsek, H; Tozun, N; Dincer, D; Idilman, R (2022)
  • Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated 
    Efe, C; Kulkarni, AV; Beretta-Piccoli, BT; Magro, B; Stattermayer, AF; Cengiz, M; Clayton-Chubb, D; Lammert, C; Bernsmeier, C; Gul, O; Higuera-de la Tijera, FH; Anders, M; Lytvyak, E; Akin, M; Purnak, T; Liberal, R; Peralta, M; Ebik, B; Duman, S; Demir, N; Balaban, Y; Urzua, A; Contreras, F; Venturelli, MG; Bilgic, Y; Medina, A; Girala, M; Gunsar, F; Londono, MC; Androutsakos, T; Kisch, A; Yurci, A; Guzelbult, F; Cagin, YF; Avci, E; Guzelbulut, M; Dindar-Demiray, EK; Harputluoglu, M; Kumar, R; Satapathy, SK; Mendizabal, M; Silva, M; Fagiuoli, S; Roberts, SK; Soylu, NK; Idilman, R; Yoshida, EM; Montano-Loza, AJ; Dalekos, GN; Ridruejo, E; Schiano, TD; Wahlin, S (2022)
    Background and Aims A few case reports of autoimmune hepatitis-like liver injury have been reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. We evaluated clinical features, treatment ...
  • Protein C, protein S and antithrombin III levels in nephrotic syndrome. 
    Buyukberber, S; Aydogdu, I; Buyukberber, NM; Bektas, A; Idilman, R; Karatan, O; Uysal, A